Lorlatinib Combinations in Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Crizotinib
Related studies linked through entity extraction aliases.
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of Crizotinib for ROS1 and MET Activated Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE3
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL
- Status
- UNKNOWN
- Phase
- PHASE4
Long Term Safety Observation of Crizotinib in Chinese NSCLC Population
- Status
- TERMINATED
- Phase
- PHASE4
Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Phase II Umbrella Study Directed by Next Generation Sequencing
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of Xalkori ROS1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
- Status
- RECRUITING
- Phase
- PHASE2
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment With Crizotinib Single Patient Expanded Access IND 134375
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2